by Fadi Agour, J.D. | Jun 26, 2026 | All Posts, Blogs
By the time you read this, the recaps will already look identical. The Supreme Court ruled 7 to 2 for Monsanto. FIFRA preempts failure-to-warn claims. Tens of thousands of Roundup cases are in jeopardy. Bayer’s stock moved. Every outlet from the wire services to...
by Haya Attia | Feb 16, 2026 | All Posts, Blogs
The “Shield” Is Gone For years, the Johnson & Johnson talc lawsuit was defined by a single stalling tactic: the “Texas Two-Step” bankruptcy maneuver. That era is officially over. The rejection of J&J’s third bankruptcy attempt in early...
by Haya Attia | Feb 5, 2026 | All Posts
Introduction: The Litigation That Won’t Go Away For many firms, the hernia mesh lawsuit landscape feels like “old news.” With major recalls dating back to 2010 (Ethicon Physiomesh) and 2016 (Atrium C-Qur), it is easy to assume the window has closed....
by Haya Attia | Jan 29, 2026 | All Posts
The New Litigation Landscape For months, the legal industry treated NEC (Necrotizing Enterocolitis) cases as a secondary focus. That changed this December. On December 17, 2025, a Connecticut jury awarded $32 million to the family of a premature infant who died after...
by Haya Attia | Jan 24, 2026 | All Posts
A Tale of Two Injuries For the past two years, “Ozempic litigation” was synonymous with stomach paralysis. But as we enter 2026, the smart money has moved. On December 15, 2025, the Judicial Panel on Multidistrict Litigation (JPML) officially approved the...
by Haya Attia | Jan 19, 2026 | All Posts
A Major Shift in the Depo-Provera Landscape If you’ve been watching the Depo-Provera litigation from the sidelines, it’s time to get in the game. For decades, the birth control shot was marketed as a convenient alternative to the pill, but as of December 2025, the...
